… Johannes Korth has received grants speaker's fee, honoraria and travel expenses from
Astellas, Basilea, Chiesi, Janssen, Novartis and Roche. The other authors declared no conflict of …

Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe
COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on
transplant recipients, with mortality rates up to 20%. Therefore, the effect of established …

SARS-CoV-2 is a worldwide challenge for the medical sector. Healthcare workers (HCW) are
a cohort vulnerable to SARS-CoV-2 infection due to frequent and close contact with COVID-…

mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of …

Vaccination against SARS-CoV-2 infection is currently approved and shows favorable
outcomes, but little known about antibody responses in solid organ transplant recipients, since …

SARS-CoV-2 infection is known to lead to severe morbidity and mortality in patients with
liver cirrhosis. For this reason, vaccination of these patients against COVID-19 is widely …

… Johannes Korth has received sponsorship to attend international conferences from Roche,
Astellas and Novartis. Benjamin Wilde has received advisory board honoraria from TEVA …

The gut microbiota contributes to maintaining human health and regulating immune responses.
Severe COVID-19 illness is associated with a dysregulated pro-inflammatory immune …

Background BK polyomavirus ( BKP yV)‐associated nephropathy (Py VAN ) is a significant
cause of premature renal transplant failure. High‐level BKP yV viremia is predictive for Py …